EUVIMEDEUVIMED entdecken
Crossref

Cytokine levels in patients with various MEFV genotypes

E. A. Deviatkina, V. D. Nazarov, S. V. Lapin, I. V. Kholopova, A. K. Musonova, D. A. Kuznetsova, S. O. Burbygina, A. V. Mazing, V. L. Emanuel

Medical Immunology (Russia) · 15.11.2026 · 28 (4) · 851-866

DOI: 10.15789/1563-0625-cli-3400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Immunology (Russia), online erschienen am 15.11.2026. Verfasst von E. A. Deviatkina und 8 weiteren Autor:innen. Die Arbeit nennt 51 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial Mediterranean fever (FMF) is a monogenic autosomal recessive autoinflammatory disease caused by MEFV gene pathogenic variants. Heterozygosity for the MEFV gene remains a clinically challenging issue, since homozygous mutations are generally required for disease manifestation. Individuals with one pathogenic variant are only mutation carriers. However, in many cases, clinical signs of FMF are exhibited in heterozygous carriers of MEFV variants. Our aim was to study the cytokine profile in patients with detected MEFV variants, taking into account molecular genetic features such as zygosity and aggressiveness of pathogenic variants. The study included 275 patients referred for MEFV genetic testing. Genomic DNA and EDTA-plasma were obtained from all subjects. Sanger sequencing of exons 2, 3, 5, and 10 of the MEFV gene was performed. Plasma levels of CRP, IL-1b, IL-6, IL-8, and IL-18 were measured by ELISA technique. A control group comprised 24 healthy donors from the laboratory biobank. Statistical analysis was carried out using GraphPad Prism 8. As based on genotyping data, 275 samples were divided into groups: wild-type genotype – WT (n = 60); FMF group included homozygous (n = 28), compound heterozygous (n = 71), and heterozygous (n = 86) carriers with combinations of pathogenic and unknown significance variants (VUS) (n = 15). For 15 samples of only VUS carriers, the cytokine levels were not measured. ELISA testing of cytokines has shown an increase of CRP, IL-1b, IL-6 and IL-18 levels in FMF compared to healthy donors (p < 0.0001). An increase of IL-6 (p < 0.05) and IL-18 levels (p < 0.0001) was found in FMF compared to the wild-type (WT) group. No differences were shown for IL-8 level between FMF, WT and healthy donors. Increased levels of CRP (p < 0.01) and IL-18 (p < 0.0001) were shown in the subgroups with aggressive homozygous variants compared to low-aggressive ones. Increased IL-18 level were observed in aggressive heterozygous cases compared to low-aggressive ones (p < 0.05). An increased level of IL-1b (p < 0.05) was shown in the subgroup with two aggressive pathogenic variants compared to subgroup with one aggressive and one low-aggressive pathogenic variant. The genotype and aggressiveness of detected variants influence the activity of the inflammatory process in patients with FMF.

Zitieren

APA

Deviatkina, E. A., Nazarov, V. D., Lapin, S. V., Kholopova, I. V., Musonova, A. K., Kuznetsova, D. A., Burbygina, S. O., Mazing, A. V., & Emanuel, V. L. (2026). Cytokine levels in patients with various MEFV genotypes. Medical Immunology (Russia), 28(4), 851-866. https://doi.org/10.15789/1563-0625-cli-3400

Vancouver

Deviatkina EA, Nazarov VD, Lapin SV, Kholopova IV, Musonova AK, Kuznetsova DA, et al. Cytokine levels in patients with various MEFV genotypes. Medical Immunology (Russia). 2026;28(4):851-866. doi:10.15789/1563-0625-cli-3400

BibTeX
@article{Deviatkina2026,
  author = {Deviatkina, E. A. and Nazarov, V. D. and Lapin, S. V. and Kholopova, I. V. and Musonova, A. K. and Kuznetsova, D. A. and Burbygina, S. O. and Mazing, A. V. and Emanuel, V. L.},
  title = {Cytokine levels in patients with various MEFV genotypes},
  journal = {Medical Immunology (Russia)},
  year = {2026},
  volume = {28},
  number = {4},
  pages = {851--866},
  doi = {10.15789/1563-0625-cli-3400}
}
Kostenlos starten →